Human Cytomegalovirus (HCMV): Infection, Risk and qPCR Detection

HCMV can be transmitted through multiple pathways. Direct transmission occurs via contact with bodily fluids such as saliva, urine, respiratory secretions, and blood. Indirect transmission may occur through contaminated surfaces. The virus can also spread through sexual contact, blood transfusion, and organ transplantation.

Vertical transmission from mother to fetus via the placenta is particularly important due to the risk of congenital infection. Because many infections are asymptomatic, individuals may unknowingly transmit the virus, making screening and laboratory detection especially important in high-risk settings.

In immunocompetent individuals, HCMV infection is usually mild or asymptomatic. However, in vulnerable populations, it can lead to severe and potentially life-threatening complications.

Congenital infection is one of the most serious consequences. Maternal infection during pregnancy can result in fetal transmission, leading to miscarriage, preterm birth, or congenital abnormalities. Affected newborns may present with jaundice, hepatosplenomegaly, thrombocytopenia, myocarditis, or hydrops fetalis. Long-term sequelae may include hearing loss, neurodevelopmental delay, and visual impairment.

In children and adults, reactivation of latent virus may occur under conditions such as pregnancy or immune suppression, potentially leading to mononucleosis-like illness or hepatitis.

Organ transplant recipients are at particularly high risk. HCMV infection can trigger graft rejection and may cause severe complications such as pneumonia or hepatitis. Similarly, immunocompromised patients, including those with HIV infection, hematologic malignancies, or those receiving immunosuppressive therapy, are at risk for disseminated disease involving multiple organ systems.

Diagnosis of HCMV infection relies on both serological and molecular methods. Serological testing includes detection of CMV-specific antibodies such as IgM and IgG, which can help determine recent or past infection.

However, molecular detection of HCMV DNA has become the cornerstone of diagnosis, especially in high-risk patients. Real-time quantitative PCR (qPCR) is widely used due to its high sensitivity, specificity, and rapid turnaround time. It enables direct detection and quantification of viral DNA, providing valuable information on viral load.

qPCR is particularly useful during the early phase of infection when antibodies may not yet be detectable. It also plays a critical role in monitoring viral replication dynamics in clinical and research settings.

Molecular detection of HCMV DNA provides several important clinical benefits. It supports early and accurate diagnosis in patients with suspected infection, especially in high-risk groups. Quantitative viral load monitoring allows clinicians to assess disease progression and evaluate treatment response.

In transplantation and transfusion medicine, nucleic acid testing helps identify infected donors or recipients, reducing the risk of virus transmission. In immunocompromised patients, regular monitoring of viral load can provide insight into immune status and help guide preventive or therapeutic interventions.

Overall, qPCR-based detection plays a central role in precision medicine approaches for HCMV management.

Preventive measures focus on reducing exposure and strengthening host immunity. Individuals with weakened immune systems should minimize contact with potential sources of infection. Pregnant women are advised to undergo regular prenatal screening and practice good hygiene to reduce the risk of primary infection.

General health measures such as maintaining good physical condition and supporting immune function may also help reduce susceptibility to infection or reactivation.